{"id":2010,"date":"2017-12-31T00:00:34","date_gmt":"2017-12-30T17:00:34","guid":{"rendered":"https:\/\/www.hivnat.org\/en\/?p=2010"},"modified":"2022-03-30T09:57:13","modified_gmt":"2022-03-30T02:57:13","slug":"a-phase-iib-randomized-active-controlled-staged-open-label-trial-to-investigate-safety-and-efficacy-of-bms-955176-in-combination-with-dolutegravir-and-atazanavir-with-or-without-ritonavir-in-trea","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/studies\/2010\/","title":{"rendered":"A phase 2b randomized, active-controlled, staged, open-label trial to investigate safety and efficacy of BMS-955176 in combination with Dolutegravir and Atazanavir (with or without Ritonavir) in treatment-experienced HIV-1 infected adults"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">This study will evaluate whether the\ncombination of&nbsp;BMS-955176 with\natazanavir (ATV) [with or without ritonavir (RTV)] and dolutegravir (DTG) is\nefficacious, safe, and well-tolerated in HIV-1 infected treatment experienced\nadults.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\t\t\t\tThis study will evaluate whether the combination of BMS-955176 with atazanavir (ATV) [with or without ritonavir (RTV)] and dolutegravir (DTG) is efficacious, safe, and well-tolerated in HIV-1 infected treatment experienced adults.\t\t<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-2010","post","type-post","status-publish","format-standard","hentry","category-studies"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=2010"}],"version-history":[{"count":1,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2010\/revisions"}],"predecessor-version":[{"id":3329,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2010\/revisions\/3329"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=2010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=2010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=2010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}